Dr. Paul Stephen Unger, MD

Dr. Unger practices at Champlain Valley Hematology Oncology in Colchester, Vermont.

Dr. Unger's NPI, 1053318766, was assigned on July 7, 2005. Dr. Unger graduated from Harvard Medical School in 1986. Dr. Unger holds Vermont license 042-0008105.

Dr. Unger's primary practice is Champlain Valley Hematology Oncology, at 792 College Pkwy, Colchester, VT 05446 in Chittenden County. The practice phone is (802) 655-3400.

Dr. Unger's primary practice is Champlain Valley Hematology Oncology in Colchester, Vermont. Dr. Unger is also affiliated with University of Vermont Medical Center. The medical group on file is Champlain Valley Hematology Oncology. Dmand AI also links Dr. Unger to 4 more hospitals, 2 medical groups, 1 group practice or clinic and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Unger practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Unger's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Unger is board certified in hematology by the American Board of Internal Medicine. Dr. Unger is licensed in Vermont.

CMS data shows 62,198 Medicare services from Dr. Unger across 33 procedure codes in 2024, for 417 Medicare patients. Medicare paid $2,186,402 for them. Every service was in an office.

CMS counts 417 Medicare patients who saw Dr. Unger in 2024. The largest group is 75 to 84, with 174 patients. 61% of them have high blood pressure, and 53% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Unger's median patient age at 77, with 63% women.

In 2024, Dr. Unger wrote 1,085 Medicare Part D claims for 200 patients. 71% of them were for generic drugs. CMS names the drug for 914 of them, across 26 drugs with 11 or more claims each, at $3,536,981 in total drug cost. In 2023, CMS named 883 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Unger for performance year 2024, reported individually. Dr. Unger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Unger as offering telehealth.

Dmand AI links 1 paper to Dr. Unger in 2021. Dr. Unger's most frequent co-authors are Avan Jamshid Armaghani, MD, Michael A. Danso, MD and Natalie R. Dickson, MD.

CMS Open Payments shows 25 general payments to Dr. Unger from 6 drug and device companies from 2020 to 2025. Travel and lodging make up the largest share, 38% of the total. Avyxa Pharma, LLC paid the most, $4,115.

Dr. Unger graduated from Harvard Medical School in 1986.